MORGAN STANLEY - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$370,011
-25.8%
123,337
-39.2%
0.00%
Q2 2023$498,732
-36.6%
202,737
-41.7%
0.00%
Q1 2023$786,196
-53.9%
347,874
-28.8%
0.00%
Q4 2022$1,705,699
-84.3%
488,739
+67.0%
0.00%
-100.0%
Q3 2022$10,831,000
+80.9%
292,610
-7.2%
0.00%0.0%
Q2 2022$5,986,000
-16.6%
315,237
+18.5%
0.00%0.0%
Q1 2022$7,181,000
-44.4%
266,065
-53.6%
0.00%
-50.0%
Q4 2021$12,917,000
+9.7%
573,321
+27.6%
0.00%0.0%
Q3 2021$11,777,000
+1295.4%
449,341
+1604.7%
0.00%
Q2 2021$844,000
+1958.5%
26,359
+2184.1%
0.00%
Q1 2021$41,000
-89.0%
1,154
-90.1%
0.00%
Q4 2020$373,000
-26.3%
11,616
-13.6%
0.00%
Q3 2020$506,000
-75.4%
13,444
-70.7%
0.00%
Q2 2020$2,053,000
+7796.2%
45,887
+5813.3%
0.00%
Q1 2020$26,000
-90.1%
776
-88.5%
0.00%
Q4 2019$263,0006,7480.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders